Blueprint Medicines to Present at Upcoming Investor Conferences

On April 11, 2023 Blueprint Medicines Corporation (Nasdaq: BPMC) reported its participation in the following upcoming investor conferences (Press release, Blueprint Medicines, APR 11, 2023, View Source [SID1234629957]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

22nd Annual Needham Healthcare Conference, held virtually, on Tuesday, April 18, 2023 at 2:15 p.m. ET.

Stifel 2023 Targeted Oncology Days, held virtually, on Tuesday, April 25, 2023 at 11:30 a.m. ET.

A live webcast of each presentation will be available by visiting the "Events and Presentations" section of Blueprint Medicines’ website at View Source A replay of the webcasts will be archived on Blueprint Medicines’ website for 30 days following each presentation.